Physician profile
Eva M Suarez
NPI 1063738045
$719.41
in general payments reported to CMS, 2019-2025
17 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.34 · 2020: $29.90 · 2021: $15.68 · 2022: $37.23 · 2023: $103 · 2024: $250 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $219.68 | 2023-2024 | Neuroblate |
| Bayer Healthcare Pharmaceuticals INC. | $76.34 | 2019 | |
| Gt Medical Technologies, INC | $58.43 | 2025 | Gammatile |
| Abbvie INC. | $56.58 | 2024-2025 | |
| Tersera Therapeutics LLC | $52.77 | 2025 | Zoladex |
| Emd Serono, INC. | $43.20 | 2023-2025 | |
| Servier Pharmaceuticals LLC | $30.84 | 2025 | |
| Incyte Corporation | $22.86 | 2022 | |
| Beone Medicines USA, INC. | $22.52 | 2025 | Tevimbra |
| Astrazeneca Pharmaceuticals Lp | $21.47 | 2024 | |
| Tempus Ai, INC | $21.21 | 2024 | |
| Novocure INC. | $18.84 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.40 | 2024 | Myrisk |
| Hologic INC | $15.68 | 2021 | |
| Pfizer INC. | $15.16 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $14.37 | 2022 | |
| Siemens Medical Solutions USA, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.